Sale of Medicines Bill R $2.8 Billion

The sale of medicines and drugs not the Brazilian Association of logistics and Distribution of pharmaceutical products (Abradilan) totaled R $2,785 billion in the first half. Over the same period last year, the result means growth of 8.3%. During the range were sold in 142 units 518,200 companies associated with the entity. According to Abradilan, the highlights are for generics, which represent 42.5% of sales in values. Between June of 2017 and 2018, marketing June totaled R $5,510 billion, 10.4% more than the previous year. The data were collected by the IQVIA.